The hypothalamus-pituitary-adrenal axis does not influence the protective effects of nociceptin/orphanin FQ on the rat gastric mucosa

Regul Pept. 2009 Apr 10;154(1-3):32-8. doi: 10.1016/j.regpep.2008.11.002. Epub 2008 Nov 21.

Abstract

The participation of hypothalamus-pituitary-adrenal axis in the gastroprotective effects of nociceptin/orphanin FQ (N/OFQ) has been investigated. Gastric mucosal lesions were induced by intragastric administration of 50% ethanol, 1 ml/rat. Rats received N/OFQ either by the intracerebroventricular (icv) route, at 3 microg/rat, or by the intraperitoneal (ip) route, at 10 microg/kg, 30 min before ethanol administration. The protective effect of icv and ip administered N/OFQ was assessed in adrenalectomized rats and in rats pretreated with the glucocorticoid receptor antagonist, mifepristone, or with the CRF receptor antagonist, alpha-helical CRF(9-41). The damaging effect of ethanol was apparently not influenced by adrenalectomy. N/OFQ markedly reduced macroscopically and histologically assessed gastric mucosal damage. The extent of reduction by N/OFQ was comparable in adrenalectomized and in sham-operated rats, with either icv or ip route of administration. Pretreatment with mifepristone, both icv (80 microg/rat) and ip (10 mg/kg) injected, did not modify the response to icv and ip N/OFQ. Pretreatment with alpha-helical CRF(9-41) (25 microg/rat icv or 250 microg/kg ip), had no effect on the reduction of gastric damage produced by icv or ip N/OFQ. Present findings suggest that the gastroprotective effects of N/OFQ on ethanol-induced damage do not involve the endocrine pathway through the HPA axis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenalectomy
  • Animals
  • Corticotropin-Releasing Hormone / antagonists & inhibitors
  • Dose-Response Relationship, Drug
  • Ethanol / toxicity
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / pathology
  • Hypothalamo-Hypophyseal System / metabolism*
  • Injections, Intraperitoneal
  • Injections, Intraventricular
  • Male
  • Mifepristone / administration & dosage
  • Nociceptin
  • Opioid Peptides / administration & dosage
  • Opioid Peptides / pharmacology*
  • Peptide Fragments / antagonists & inhibitors
  • Pituitary-Adrenal System / metabolism*
  • Rats
  • Rats, Wistar
  • Receptors, Glucocorticoid / antagonists & inhibitors
  • Stomach Diseases / chemically induced
  • Stomach Diseases / pathology*
  • Stomach Diseases / prevention & control*
  • Time Factors

Substances

  • Opioid Peptides
  • Peptide Fragments
  • Receptors, Glucocorticoid
  • Mifepristone
  • Ethanol
  • Corticotropin-Releasing Hormone
  • corticotropin releasing hormone (9-41)